摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(苄基氨基)-4-乙氧基-3-环丁烯-1,2-二酮 | 144913-06-4

中文名称
3-(苄基氨基)-4-乙氧基-3-环丁烯-1,2-二酮
中文别名
——
英文名称
3-benzylamino-4-ethoxycyclobut-3-ene-1,2-dione
英文别名
3-(Benzylamino)-4-ethoxycyclobut-3-ene-1,2-dione
3-(苄基氨基)-4-乙氧基-3-环丁烯-1,2-二酮化学式
CAS
144913-06-4
化学式
C13H13NO3
mdl
MFCD00179351
分子量
231.251
InChiKey
JFBJJNQPIJHMPP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    17
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    55.4
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 危险品标志:
    Xi
  • 危险类别码:
    R36/37/38
  • 安全说明:
    S26,S37/39

SDS

SDS:7308636d89eca46a1cba4a92b885100a
查看
Name: 3-(Benzylamino)-4-ethoxycyclobut-3-ene-1 2-dione 97% Material Safety Data Sheet
Synonym:
CAS: 144913-06-4
Section 1 - Chemical Product MSDS Name:3-(Benzylamino)-4-ethoxycyclobut-3-ene-1 2-dione 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
144913-06-4 3-(Benzylamino)-4-ethoxycyclobut-3-ene 97% unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 144913-06-4: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white crystalline solid
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 68 - 72 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C13H13NO3
Molecular Weight: 231

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, acids, bases.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 144913-06-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3-(Benzylamino)-4-ethoxycyclobut-3-ene-1,2-dione - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 144913-06-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 144913-06-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 144913-06-4 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Bioisosteric replacement of the .alpha.-amino carboxylic acid functionality in 2-amino-5-phosphonopentanoic acid yields unique 3,4-diamino-3-cyclobutene-1,2-dione containing NMDA antagonists
    摘要:
    In this report, a novel bioisostere of the alpha-amino acid 3,4-diamino-3-cyclobutene-1,2-dione, has been incorporated into a series of compounds which are NMDA antagonists. These compounds, which are achiral and easily prepared, demonstrated good affinity at the NMDA receptor by their ability to displace [H-3]CPP binding in vitro. In particular, the phosphonic acid 24 provided protection against NMDA-induced lethality in mice equivalent to 2-amino-7-phosphonoheptanoic acid (5). This was considered an encouraging result in lieu of the fact that 24, like 5, lacks the conformational rigidity of the more potent NMDA antagonists. In addition, analogs that incorporate the 1,2,4-oxadiazolidine-3,5-dione heterocycle of quisqualic acid and the unsaturation of kainic acid were prepared to explore selectivity at the non-NMDA receptor subtypes.
    DOI:
    10.1021/jm00103a010
  • 作为产物:
    描述:
    方酸二乙酯苄胺乙醇 为溶剂, 以83%的产率得到3-(苄基氨基)-4-乙氧基-3-环丁烯-1,2-二酮
    参考文献:
    名称:
    合理设计的方酸二酰胺——一类新型的糖核苷酸模拟物?†
    摘要:
    糖核苷酸,如 GDP-甘露糖, GDP-岩藻糖 和 UDP-葡萄糖 是重要的生物分子,在碳水化合物和 糖缀合物生物合成、代谢和细胞信号传导。天然存在的糖核苷酸的类似物和模拟物作为化学工具和糖核苷酸依赖性酶(包括糖基转移酶)的抑制剂候选物而受到追捧。许多糖核苷酸通过协调它们的目标糖基转移酶二磷酸盐组为活性位点中的二价金属辅因子。因此,鉴定不带电荷的、化学稳定的二磷酸基团替代物,具有与二价金属配位的能力,因此是开发糖核苷酸模拟物的重要设计标准。在这里,我们描述了基于方酸二酰胺支架的新型糖核苷酸模拟物的合理设计和合成。磷酸盐等排。我们通过全面的 NMR 滴定实验证明,新的糖核苷酸模拟物有效地协调了镁2+,并提供来自与治疗相关的甘露糖基转移酶的生物学研究结果 锥虫布氏锥虫。我们的研究结果表明,方酸二酰胺是开发糖核苷酸模拟物的有前途的模板,并说明方二酰胺基团作为抑制剂设计片段的巨大潜力。
    DOI:
    10.1039/c004165c
点击查看最新优质反应信息

文献信息

  • Sialic acid dimers
    申请人:Brossmer Reinhard
    公开号:US09260467B2
    公开(公告)日:2016-02-16
    Sialic acid derivatives of the formula (I) in which the symbols have the definitions stated in the description are suitable as medicaments, more particularly for diseases whose course is influenced by Siglec ligands.
    公式(I)中的唾液酸衍生物 其中符号的定义如描述中所述,适用作为药物,更具体地用于受Siglec配体影响的疾病。
  • Chiral Aminoalcohols and Squaric Acid Amides as Ligands for Asymmetric Borane Reduction of Ketones: Insight to In Situ Formed Catalytic System by DOSY and Multinuclear NMR Experiments
    作者:Yana Nikolova、Georgi M. Dobrikov、Zhanina Petkova、Pavletta Shestakova
    DOI:10.3390/molecules26226865
    日期:——
    insight on the in situ formation and stability at room temperature of intermediates generated from ligands and borane as possible precursors of the oxazaborolidine-based catalytic system has been obtained by 1H DOSY and multinuclear 1D and 2D (1H, 10/11B, 13C, 15N) NMR spectroscopy of equimolar mixtures of borane and selected ligands. These results contribute to better understanding the complexity of the
    在用 BH 3 ·SMe 2还原 α-氯苯乙酮的模型反应中,对一系列方酸酰胺(以 66-99% 的分离产率合成)和一组手性氨基醇作为配体进行了比较研究。在所有情况下,氨基醇都表现出更好的效率(高达 94% ee ),而相应的方酰胺仅实现了较差的不对称诱导。通过1 H DOSY 和多核 1D 和 2D ( 1 H, 10/11 B , 13 C, 15 N) 硼烷和选定配体的等摩尔混合物的NMR谱。这些结果有助于更好地理解在可能形成恶唑硼烷之前反应混合物中发生的过程的复杂性,这对于 α-氯苯乙酮硼烷还原中实现的对映选择性程度起着至关重要的作用。
  • Modularly Evolved 2-AminoDMAP/Squaramides as Highly Active Bifunctional Organocatalysts in Michael Addition
    作者:Murat Işık、M. Yagiz Unver、Cihangir Tanyeli
    DOI:10.1021/jo5022597
    日期:2015.1.16
    We report a new family of chiral bifunctional acid/base type organocatalysts, 2-aminoDMAP/Squaramides, which are proved to be highly active (1 mol % cat. loading) promoters in conjugate addition of dibenzoylmethane to various trans-β-nitroalkenes. Steric demand of the catalysts was clearly seen by a set-by-set modulation of the squaramide unit through electronic and steric factors. The synergistic
    我们报道了一个新的手性双官能酸/碱型有机催化剂,2-aminoDMAP / Squaramides家族,被证明是在将二苯甲酰甲烷共轭加成到各种反式-β-硝基烯烃中的高活性(1 mol%催化剂负载量)促进剂。通过电子和空间因素对方酰胺单元进行逐组调节,可以清楚地看到催化剂的立体需求。2-氨基DMAP“超强碱”与空间受限的方酰胺(氢键供体)的协同作用,使得在短短几个小时内即可将一系列反应物完全转化为相应的迈克尔加成物,且选择性极高(ee高达98%)。
  • Tether-Free Immobilized Bifunctional Squaramide Organocatalysts for Batch and Flow Reactions
    作者:György Kardos、Tibor Soós
    DOI:10.1002/ejoc.201300626
    日期:2013.7
    accessible, and robust immobilized bifunctional organocatalysts. There was no need to employ any tether to secure high enantio- and diastereoselectivities in various Michael addition reactions. The synthetically useful Michael adducts were obtained within reasonable reaction times with the advantage of easy product isolation and the possibility of automation by using a flow chemistry apparatus.
    本文描述了高效、易于获取且稳健的固定化双功能有机催化剂的制备。在各种迈克尔加成反应中不需要使用任何系链来确保高对映选择性和非对映选择性。合成有用的迈克尔加合物是在合理的反应时间内获得的,优点是易于分离产物,并且可以通过使用流动化学装置实现自动化。
  • Sialic Acid Dimers
    申请人:Brossmer Reinhard
    公开号:US20150005245A1
    公开(公告)日:2015-01-01
    Sialic acid derivatives of the formula (I) in which the symbols have the definitions stated in the description are suitable as medicaments, more particularly for diseases whose course is influenced by Siglec ligands.
    式(I)中符号的定义如描述中所述,适用于药物,尤其适用于受Siglec配体影响的疾病。其中的唾液酸衍生物。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐